<!DOCTYPE html>
<html lang="en">
<head>

<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Kratom Adverse Events | FDA FAERS & CAERS (Mitragynine)</title>

<meta name="description" content="Legislative reference page summarizing FDA adverse event reporting signals for kratom/mitragynine using FAERS and CAERS headline counts. Snapshot captured January 2026.">

<meta name="keywords" content="kratom adverse events, mitragynine FAERS, mitragynine CAERS, FDA adverse event reporting, kratom hospitalizations, kratom deaths reports">

<meta name="author" content="Kratom Regulatory Review">
<meta name="theme-color" content="#0c2d48">

<link rel="canonical" href="https://kratomregulatoryreview.org/adverse.html">

<!-- Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-MQKC65VZVY"></script>
<script async src="https://www.googletagmanager.com/gtag/js?id=G-P31PD1SSTD"></script>
<script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config','G-MQKC65VZVY');
gtag('config','G-P31PD1SSTD');
</script>

<link rel="stylesheet" href="css/style.css">

<style>
  .page-header { padding: 40px 0 25px 0; }
  .page-intro { max-width: 900px; margin-bottom: 12px; line-height: 1.7; }
  .page-note { max-width: 900px; font-size: 14px; color: #4b5563; margin-bottom: 15px; }
  .meta-line { font-size:14px; color:#4b5563; margin-top:10px; font-weight:600; }

  .accordion { max-width:1100px; margin:40px auto; }
  .accordion-item { border:1px solid #e2e8f0; border-radius:12px; margin-bottom:18px; overflow:hidden; }
  .accordion-header { background:#0c2d48; color:#fff; padding:18px; font-size:18px; font-weight:600; cursor:pointer; }
  .accordion-content { display:none; padding:20px; background:#f9fafb; }

  .case-list { list-style:none; padding:0; margin:0; display:grid; gap:16px; }

  .data-card { border:1px solid #e2e8f0; border-radius:10px; padding:16px; background:#fff; }
  .data-title { font-weight:700; font-size:16px; margin-bottom:6px; }
  .data-subtitle { font-size:14px; color:#4b5563; margin-bottom:10px; line-height:1.6; }

  .pill { display:inline-block; font-size:12px; font-weight:600; padding:6px 10px; border-radius:999px; background:#e7eef7; color:#0c2d48; margin-bottom:10px; }

  .metrics-grid { display:grid; grid-template-columns:1fr 1fr; gap:12px; margin-top:10px; }
  .metric-box { border:1px solid #e2e8f0; border-radius:10px; padding:14px; background:#ffffff; }
  .metric-label { font-size:13px; color:#6b7280; margin-bottom:4px; }
  .metric-value { font-size:26px; font-weight:800; line-height:1.1; color:#111827; }

  .metric-value.danger { color:#b91c1c; }
  .metric-value.warn { color:#b45309; }

  .link-row { margin-top:14px; display:flex; flex-wrap:wrap; gap:10px; }
  .case-link { font-size:14px; text-decoration:none; color:#0c2d48; border:1px solid #0c2d48; padding:8px 12px; border-radius:10px; display:inline-block; font-weight:600; }
  .case-link:hover { background:#0c2d48; color:#fff; }

  .brief-table { width:100%; border-collapse:collapse; margin-top:14px; background:#fff; border:1px solid #e2e8f0; border-radius:12px; overflow:hidden; }
  .brief-table th, .brief-table td { padding:12px; border-bottom:1px solid #e2e8f0; text-align:left; font-size:14px; vertical-align:top; }
  .brief-table th { background:#f1f5f9; font-weight:700; }
  .brief-table tr:last-child td { border-bottom:none; }

  .small { font-size:13px; color:#6b7280; margin-top:10px; line-height:1.6; }

  .footer { background:#0c2d48; color:#fff; padding:30px 0; text-align:center; margin-top:40px; }
</style>

<script>
document.addEventListener("DOMContentLoaded", function(){
  const headers = document.querySelectorAll(".accordion-header");
  headers.forEach(header=>{
    header.addEventListener("click",()=>{
      const content = header.nextElementSibling;
      content.style.display = content.style.display === "block" ? "none" : "block";
    });
  });
});
</script>

</head>

<body>

<div class="gov-banner">
üá∫üá∏ Informational public health resource. Educational reference for legislative and regulatory review.
</div>

<header class="site-header">
  <div class="container header-inner">
    <div class="site-title">Kratom Regulatory Review</div>
  </div>
</header>

<nav class="main-nav">
  <div class="container nav-inner">
    <a href="index.html">Overview</a>
    <a href="mortality.html">Mortality</a>
    <a href="adverse.html" class="active">Adverse Events</a>
    <a href="KratomCaseReports.html">Case Reports</a>
  </div>
</nav>

<section class="page-header">
  <div class="container">
    <h1>FAERS + CAERS ‚Ä¢ Kratom (Mitragynine)</h1>

    <p class="page-intro">
      This page summarizes FDA adverse event reporting signals for kratom/mitragynine using two federal
      spontaneous reporting systems: <strong>CAERS</strong> (foods & dietary supplements) and <strong>FAERS</strong> (drugs & biologics).
      These systems help detect safety signals from real-world reports.
    </p>

    <p class="page-note">
      Reports in FAERS and CAERS are voluntary and may be incomplete or duplicative.
      They describe reported associations and do not independently establish incidence or causation.
    </p>

    <div class="meta-line">Snapshot captured: <strong>January 2026</strong></div>
  </div>
</section>

<div class="accordion">

<!-- ================= HEADLINE TABLE ================= -->

<div class="accordion-item">
  <div class="accordion-header">
    Headline Counts (Kratom/Mitragynine)
  </div>

  <div class="accordion-content">
    <div class="data-card">
      <div class="data-title">Legislative Summary Table</div>
      <div class="data-subtitle">
        Headline counts below reflect reports filtered to kratom/mitragynine, using MAHA‚Äôs compiled snapshots
        (January 2026). ‚ÄúDeaths‚Äù and ‚ÄúHospitalizations‚Äù reflect outcomes recorded in reports.
      </div>

      <table class="brief-table">
        <thead>
          <tr>
            <th style="width:26%;">Dataset</th>
            <th style="width:18%;">Scope</th>
            <th style="width:14%;">Total reports</th>
            <th style="width:14%;">Deaths</th>
            <th style="width:14%;">Hospitalizations</th>
            <th style="width:14%;">Other</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>FDA CAERS</strong><br><span class="small">Foods & Dietary Supplements</span></td>
            <td>Kratom / Mitragynine only</td>
            <td><strong>743</strong></td>
            <td><strong>258</strong></td>
            <td><strong>191</strong></td>
            <td><strong>Serious cases:</strong> 404</td>
          </tr>
          <tr>
            <td><strong>FDA FAERS</strong><br><span class="small">Drugs & Biologics</span></td>
            <td>Kratom / Mitragynine only</td>
            <td><strong>1,470</strong></td>
            <td><strong>722</strong></td>
            <td><strong>370</strong></td>
            <td><strong>% with death outcome:</strong> 49%</td>
          </tr>
        </tbody>
      </table>

      <div class="small">
        Data source: MAHA FAERS/CAERS kratom (mitragynine) snapshots. Dataset last updated in MAHA: <strong>January 20, 2026</strong>.
      </div>

      <div class="link-row">
        <a class="case-link" href="https://www.mothersagainstherbalabuse.org/literature/adverseeventskratom.html" target="_blank">View MAHA Source Page ‚Üí</a>
      </div>
    </div>
  </div>
</div>


<!-- ================= CAERS ================= -->

<div class="accordion-item">
  <div class="accordion-header">
    FDA CAERS (Foods & Dietary Supplements)
  </div>

  <div class="accordion-content">
    <div class="data-card">
      <div class="pill">KRATOM ‚Ä¢ MITRAGYNINE</div>
      <div class="data-title">Mitragynine (Kratom) ‚Äî CAERS Snapshot</div>
      <div class="data-subtitle">
        CAERS is FDA CFSAN‚Äôs adverse event reporting system for foods and dietary supplements.
        Reports do not prove causation, but they can help identify safety signals and patterns.
      </div>

      <div class="metrics-grid">
        <div class="metric-box">
          <div class="metric-label">Total reports</div>
          <div class="metric-value">743</div>
        </div>
        <div class="metric-box">
          <div class="metric-label">Deaths (reported outcome)</div>
          <div class="metric-value danger">258</div>
        </div>
        <div class="metric-box">
          <div class="metric-label">Hospitalizations (reported outcome)</div>
          <div class="metric-value warn">191</div>
        </div>
        <div class="metric-box">
          <div class="metric-label">Serious cases (reported classification)</div>
          <div class="metric-value">404</div>
        </div>
      </div>

      <div class="small" style="margin-top:12px;">
        Dataset last updated (MAHA snapshot): <strong>January 20, 2026</strong>.
      </div>

      <div class="link-row">
        <a class="case-link" href="https://www.fda.gov/food/foodborneillnesscontaminants/cfsan-adverse-event-reporting-system-caers" target="_blank">
          FDA CAERS Overview ‚Üí
        </a>
        <a class="case-link" href="https://www.mothersagainstherbalabuse.org/literature/adverseeventskratom.html" target="_blank">
          MAHA CAERS Snapshot Page ‚Üí
        </a>
      </div>
    </div>
  </div>
</div>


<!-- ================= FAERS ================= -->

<div class="accordion-item">
  <div class="accordion-header">
    FDA FAERS (Drugs & Biologics)
  </div>

  <div class="accordion-content">
    <div class="data-card">
      <div class="pill">KRATOM ‚Ä¢ MITRAGYNINE</div>
      <div class="data-title">Mitragynine (Kratom) ‚Äî FAERS Snapshot</div>
      <div class="data-subtitle">
        FAERS is the FDA‚Äôs adverse event reporting system for drugs and biologics.
        Like CAERS, it detects safety signals from reported outcomes and does not, by itself, prove causation.
      </div>

      <div class="metrics-grid">
        <div class="metric-box">
          <div class="metric-label">Total reports</div>
          <div class="metric-value">1,470</div>
        </div>
        <div class="metric-box">
          <div class="metric-label">Deaths (reported outcome)</div>
          <div class="metric-value danger">722</div>
        </div>
        <div class="metric-box">
          <div class="metric-label">Hospitalizations (reported outcome)</div>
          <div class="metric-value warn">370</div>
        </div>
        <div class="metric-box">
          <div class="metric-label">% with death outcome</div>
          <div class="metric-value">49%</div>
        </div>
      </div>

      <div class="small" style="margin-top:12px;">
        Dataset last updated (MAHA snapshot): <strong>January 20, 2026</strong>.
      </div>

      <div class="link-row">
        <a class="case-link" href="https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard" target="_blank">
          FDA FAERS Public Dashboard ‚Üí
        </a>
        <a class="case-link" href="https://www.mothersagainstherbalabuse.org/literature/adverseeventskratom.html" target="_blank">
          MAHA FAERS Snapshot Page ‚Üí
        </a>
      </div>
    </div>
  </div>
</div>


<!-- ================= HOW TO INTERPRET ================= -->

<div class="accordion-item">
  <div class="accordion-header">
    How to Interpret These Datasets (Plain Language)
  </div>

  <div class="accordion-content">
    <div class="data-card">
      <div class="data-title">What these numbers mean</div>
      <p style="font-size:14px; color:#374151; line-height:1.7; margin:0;">
        FAERS and CAERS are designed to help detect safety signals ‚Äî patterns that may warrant closer review.
        Reports can be submitted by health professionals, consumers, and manufacturers. A report may include
        multiple products or substances, and reporting intensity can change over time based on media attention,
        product labeling, and clinical awareness.
      </p>
      <p style="font-size:14px; color:#374151; line-height:1.7; margin:12px 0 0 0;">
        These datasets are useful for identifying what outcomes are being reported (e.g., hospitalization or death),
        but they do not establish how often an outcome occurs in the population and do not independently prove that
        kratom caused the outcome.
      </p>
    </div>
  </div>
</div>

</div>

<footer class="footer">
  <div class="container">
    <p>¬© 2026 Kratom Regulatory Review</p>
  </div>
</footer>

</body>
</html>
